Karyopharm Therapeutics (KPTI) Announces Appointment of Richard Paulson as President and CEO

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. HUVR:IN
2. DELL
3. ROIV
4. ANET
5. NKE
6. PANW
7. CL
8. SNDK
9. TAP
10. EAT

Go back to Karyopharm Therapeutics (KPTI) Announces Appointment of Richard Paulson as President and CEO

Karyopharm Therapeutics (KPTI) Misses Q1 EPS by 6c, Revenues Miss

May 3, 2021 7:07 AM EDT

Karyopharm Therapeutics (NASDAQ: KPTI) reported Q1 EPS of ($0.77), $0.06 worse than the analyst estimate of ($0.71). Revenue for the quarter came in at $23.26 million versus the consensus estimate of $25.75 million.

"We are encouraged to see patient demand for XPOVIO return to growth in the first quarter of 2021, and we remain confident in its long-term commercial potential and our ability to further increase utilization and... More